Colombia Medical Device Registration Cost 2026: INVIMA Representative Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

How Much Does It Cost to Register a Medical Device in Colombia in 2026?

For a single foreign-manufactured device entering Colombia in 2026, expect a 3-year all-in budget of roughly USD 4,500–11,000 for Class I/IIa (uncontrolled pathway) and USD 7,000–22,000 for Class IIb/III (controlled pathway), excluding INVIMA government fees, trademark filings, CCAA charges, and clinical evidence. The wide range is not driven by INVIMA — government fees are published and predictable. It is driven almost entirely by how your Colombia Representative (Representante Legal) bills you.

Three pricing models dominate the Colombian local-rep market today, and the difference between the cheapest and most expensive can exceed 4x over three years for the same scope of work:

Colombia Rep Pricing Model	Year 1 Cost (Class IIa, 1 device)	Year 1 Cost (Class III, 1 device)	3-Year Total (Class IIa)	3-Year Total (Class III)
Hourly billing	$4,500–$9,000	$12,000–$22,000	$9,500–$16,000	$20,000–$38,000
Registration fee + lower annual	$3,500–$6,500	$7,000–$13,000	$6,500–$13,000	$13,000–$26,000
Flat all-inclusive annual fee	$2,000	$3,000	$6,000	$9,000

Government fees (Class I/IIa MD COL 3,898,330; Class IIb/III COL 4,412,400; IVD Class I/II COL 2,570,590) are the same regardless of representative. Your rep's bill is where you have leverage. This guide is about how to use it.

Skip to Your Scenario

• Single Class I or IIa device, pre-revenue startup: Read Scenario A first — flat fee saves $5,500–$7,000 in Year 1 cash.
• Single Class IIb or III device entering Colombia: Read Scenario B — Year 1 burden under hourly is 65–75% of 3-year cost.
• Multi-device portfolio (3+ devices): Read Scenario C — tier discounts compound dramatically.
• Already have a Colombia Representative and want to switch: Skip to the Colombia Rep Switching Playbook.
• Issuing an RFP this week: Skip to the RFP Template and 8 questions to ask.
• Want to validate the numbers: Read the Named Provider RFP Comparison.

For step-by-step regulatory mechanics — classification, dossier, UDI-DI, technovigilance — see the companion guide: Colombia INVIMA Medical Device Registration: Complete Guide. This article stays narrowly on buyer-side procurement of representative services.

Why Colombia Representative Pricing Is Where Colombia Budgets Win or Lose

Colombia requires every foreign manufacturer to appoint a Representante Legal — a legal entity domiciled in Colombia that holds the INVIMA registro sanitario, signs filings, manages modifications and renewals, coordinates with the CCAA-certified importer, files UDI-DI submissions in the IDIS platform, and serves as INVIMA's point of contact for technovigilance and inspections.

The Colombia Representative is not optional and not a one-time cost. The relationship runs for as long as your device is on the Colombian market. Under Decree 1782 of 2014 and the renewal regime aligned with Decreto 410 of 2024, registros sanitarios are valid for 10 years and renewable indefinitely. Unlike a 510(k) engagement that ends when FDA clears the device, a Colombia Representative is a recurring vendor relationship — small differences in pricing model compound enormously over the device life.

This is one of the few line items in international registration where the buyer has real negotiating leverage:

• Scope is well-defined and standardized (registration, modifications, renewals, UDI-DI, technovigilance liaison, CCAA coordination).
• Multiple firms can perform the same statutory role.
• Switching is possible — INVIMA has a defined holder-change procedure.
• INVIMA's fee schedule is published in the annual Acuerdo de Tarifas, so the rep cannot mark up government fees opaquely.

The catch: most Colombia Representative pricing is not published. You have to issue an RFP and compare proposals where every firm has a different scope inclusion list — some include the CCAA importer certificate, some do not; some include trademark filings, some bill them separately; some include UDI-DI submissions in IDIS, some bill them per code. That is exactly the comparison this article is designed to short-circuit.

The Three Colombia Representative Pricing Models, Decoded

Model 1: Hourly billing ("charge by hour")

The default for small-to-mid Colombian regulatory firms and the historical industry standard. Scope is captured in a Statement of Work; everything out-of-scope (a Legal Modification, an extra UDI-DI submission) is billed at hourly rates that run $130–$300/hour by tier:

Consultant Tier	Colombia Hourly Rate (2026)	Typical Work
Tier 1 — senior regulatory strategist	$290–$340/hr	Decree 4725 / Decreto 410 strategy, INVIMA escalations, trademark disputes
Tier 2 — regulatory specialist	$215–$265/hr	Dossier preparation, Spanish dossier review, INVIMA query responses
Tier 3 — associate / documentation	$115–$155/hr	Translations, UDI-DI semantic submissions, file maintenance

(Source: MedDeviceGuide Medical Device Regulatory Consulting Hourly Rates by Region. Colombia tracks just below Mexico/Brazil in regional benchmarks.)

Why buyers choose hourly: flexibility, perceived control, use only when needed.

Why hourly is bad for buyers in practice:

• No incentive to be efficient. Every hour the representative spends is revenue. There is no economic reason to optimize or reuse a Spanish-translation template.
• Surprise invoices. "Quick check on the IDIS portal" becomes 4 hours. CFS verification becomes 6 hours. The bill arrives 60 days later.
• Scope creep is invisible until it bills. A Legal Modification to update labeling can be 2 hours or 20 — you find out after.
• Disincentive to communicate. Every email is potentially billable, so you ask fewer questions and end up with worse outcomes.
• Year 1 cash flow shock. First-year work (registration filing, Spanish translation, CCAA coordination, trademark application, UDI-DI uploads) is frequently 3–5x the steady-state annual hours.

A typical Class III hourly engagement for a single device runs $12,000–$22,000 in Year 1 and $2,500–$6,000/year thereafter, with variance driven by INVIMA query volume.

Model 2: Registration fee + lower annual maintenance

The dominant model for mid-to-large Colombian regulatory firms today (Emergo, Freyr, Artixio, MedEnvoy, MDRC, Veraque, and most LATAM boutiques). Buyer pays a one-time setup/registration fee plus a smaller recurring annual fee. Scope is bundled but each "extra" is itemized.

Typical structure:

Component	Class I / IIa (Uncontrolled)	Class IIb / III (Controlled)
One-time setup fee	$1,000–$2,500	$2,000–$4,000
Initial registration filing	$1,800–$3,500	$3,500–$8,000
Annual maintenance fee	$1,200–$2,500	$2,500–$5,000
Per-modification fee (Legal)	$400–$1,200	$800–$2,500
Per-modification fee (Technical)	$600–$2,000	$1,500–$4,500
UDI-DI submission setup	$300–$1,000	$300–$1,000
CCAA importer arrangement	$500–$2,500 / year	$500–$2,500 / year
Trademark filing support	$800–$2,000 per mark	$800–$2,000 per mark
Renewal filing (Year 10)	$1,500–$3,500	$2,500–$6,000

The trap: the marketing message is "low annual fee," but Year 1 actual spend is $3,500–$13,000 because every registration triggers setup + filing + UDI-DI + trademark + CCAA simultaneously.

Where this model fails buyers:

• Year 1 cash flow shock is structural. All major one-time fees fire in the same calendar year you have not yet started selling.
• Modifications are unbounded. Colombia's active regulatory environment (Decreto 410/2024, Resolution 2024041 UDI-DI mandates, IDIS launch, EU MDR/IVDR alignment) generates 1–3 modification filings per device per year. At $800–$2,500 each, that is a $1,500–$6,000/year invisible tax.
• UDI-DI filings scale with SKU count. Per Resolution 2024041, every variant requires a UDI-DI code in IDIS. Some firms charge $50–$200 per code.
• Renewal cliff. At Year 10, the renewal triggers a $2,500–$6,000 fee window most buyers forget to budget. Decreto 410 keeps the 10-year cycle intact.
• Trademark surprise. INVIMA registrations require a brand-name trademark with the Superintendencia de Industria y Comercio (SIC); many representatives discover this post-contract and bill it as an extra.

Model 3: Flat all-inclusive annual fee

A newer pricing model where the Colombia Representative charges a single annual fee that includes the initial filing, all modifications (Legal, Technical, combined), all UDI-DI submissions, all translations, the CCAA Importer Certificate where required, and the Year-10 renewal. Same number every year.

Two structural advantages:

1. Fee curve is flat instead of front-loaded. Year 1 cost equals Year 2 cost equals Year 3 cost. The pre-revenue period is no longer cash-flow-hostile.
2. Rep's incentives align with yours. Once you sign, every additional hour the rep spends is pure cost to them. They are economically motivated to file cleanly and avoid INVIMA queries.

The catch: flat-fee reps typically require a multi-year contract (to amortize Year 1 work) and exclude government fees, certified translations for non-INVIMA authorities, and importation handling itself.

This model is rare. As of April 2026, Pure Global is the only major Colombia Representative service provider that publishes a complete flat-fee schedule on its website (pureglobal.com/services/pricing), making it the only published reference point for buyers. Emergo, Freyr, Artixio, MedEnvoy, Veraque, MDRC, and bioaccess all quote on RFP only.

Why this guide uses Pure Global as the worked example

We use Pure Global's published rates throughout this article because they are the only flat-fee Colombia rep rates in the public domain — anyone can verify them at pureglobal.com/services/pricing. This is not an endorsement. The published rates simply let us do an apples-to-apples cash flow comparison that would otherwise require RFPs to multiple firms under NDA. Industry ranges for hourly and front-loaded models are based on typical RFP responses, published consulting hourly benchmarks, and procurement data collected by MedDeviceGuide.

Recommended Reading

Mexico Medical Device Registration Cost 2026: MRH Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

Regulatory Reimbursement & Market Access2026-04-24 · 40 min read

Pure Global Colombia Representative Pricing (Published, April 2026)

Pure Global splits Colombia pricing into two tier tables: lower-risk devices (medical device Class I/IIa, IVD Class I/II) on the "uncontrolled" pathway, and higher-risk devices (medical device Class IIb/III, IVD Class III) on the "controlled" pathway with full technical evaluation.

Class I / IIa Medical Devices and Class I / II IVDs — Uncontrolled Pathway

Number of Registrations	Annual Flat Fee (USD)
1	$2,000
2	$3,000
3	$4,000
4	$5,000
5	$6,000
6	$6,500
7	$7,000
8	$7,500
9	$8,000
10	$8,500
11+	Custom quote

Class IIb / III Medical Devices and Class III IVDs — Controlled Pathway

Number of Registrations	Annual Flat Fee (USD)
1	$3,000
2	$4,500
3	$6,000
4	$7,500
5	$9,000
6	$10,000
7	$11,000
8	$12,000
9	$13,000
10	$14,000
11+	Custom quote

Included in the annual fee — per Pure Global's published price list:

• Preparation and submission of the registration (INVIMA registro sanitario)
• Required translation of submission documents into Spanish
• Modifications — the price list does not segment Legal vs Technical vs combined, so all three modification types fall inside this line
• Renewals (the 10-year sanitary registration cycle under Decreto 1782/2014 / Decreto 410/2024)
• Correspondence with authorities (INVIMA) on the registered devices
• CCAA Importer Certificate — included in the annual fee if required (per Pure Global's price-list wording)
• Pure Colombia as the owner of the registration — included in the annual fee if required (so the registration is not held by a distributor)
• Support with UDI-DI codes submission — included in the annual fee if required (per Resolution 2024041 in IDIS)

Inherent to the Colombia Representative statutory role under Decreto 1782/2014 and Resolución 4002/2007 (included by definition, not separately billable):

• Acting as INVIMA's regulatory point of contact for the registered device (Decreto 1782/2014 art. on titularidad de registro sanitario)
• Holding the registro sanitario in the representative's name on behalf of the foreign manufacturer where so contracted
• Forwarding INVIMA notices and requirements to the manufacturer

Confirm scope before signing — these activities are not itemized on Pure Global's published price list, so verify in writing whether they sit inside the annual fee or are billed as ad-hoc consulting at $150/hour:

• INVIMA query / clarification responses during controlled-pathway technical evaluation (the price list lists "correspondence with authorities" but does not separately itemize substantive query response work, especially for Class IIb/III dossier challenges)
• Technovigilance / adverse event reporting and triage under Resolución 4816/2008 (forwarding may be inherent; investigation, root-cause, and FSCA drafting are typically ad-hoc consulting)
• Post-market surveillance reporting to INVIMA beyond mandate-required forwarding
• CCAA importer onboarding letters and CCAA-data updates beyond the initial Importer Certificate
• Inspection support if INVIMA conducts an audit of the importer or of the holder's records

Not included — separately quoted on Pure Global's consulting menu (see Other Pure Global Colombia Service Rates below):

• Trademark filing with the SIC — $1,500 per device trademark plus SIC government fee (COL 1,288,000–1,714,500)
• Ad-hoc consulting / out-of-scope work — $150 per hour
• Translation beyond what is included with the registration — $7 per page (translation) / $4 per page (translation review)

Government fees passed through at cost (no markup): INVIMA Application Assessment Fees (COL 2,570,590–4,412,400 by class), Trademark Application Fee with SIC (COL 1,288,000–1,714,500), Modification fees (COL 866,471–1,259,319), UDI-DI Code Addition (COL 13,200 up to 182 codes). See Government Fees: A Quick Reference below.

Not included (separate commercial relationships, not Pure Global services):

• Certified translations for non-INVIMA authorities (e.g., Ministry of Health labeling for procurement tenders)
• Importation handling itself by the CCAA importer (separate commercial relationship between manufacturer and importer)
• Clinical investigation costs for Class IIb/III devices
• Customs brokerage and freight

Other Pure Global Colombia Service Rates

Service	Rate
Trademark Support Colombia	$1,500 per device trademark
Ad-hoc consulting (out-of-scope)	$150 per hour
Translation (per page, when not bundled)	$7 per page
Translation review (per page, when not bundled)	$4 per page

Contract Terms

• Standard contract: 3 years.
• Annual contract option: available, but the first-year fee is increased by 50%.
• Early termination: allowed at any time with a 50% payoff of the remaining contract value.
• Ad-hoc consulting (non-clients or out-of-scope work): $150/hour.

(Source: pureglobal.com/services/pricing, captured April 2026. Price list version 1.2, last updated 2026-04-02.)

3-Year Cash Flow: Side-by-Side Comparison

The pricing model only matters because of cash timing. The scenarios below show the same scope — one device, rep services only, government fees excluded — under each of the three models. Numbers are illustrative and based on the ranges above.

Scope assumption. The Pure Global flat-fee column in these scenarios assumes that (a) INVIMA query / clarification responses during controlled-pathway technical evaluation, and (b) routine technovigilance forwarding under Resolución 4816/2008, are inside the published "correspondence with authorities" line. Pure Global's published price list lists "preparation and submission of the registration, required translation, modifications, renewals, and correspondence with authorities" plus "if required" CCAA Importer Certificate, registration ownership, and UDI-DI codes submission support — substantive query response work and adverse-event investigation are not separately itemized. For Class IIb/III scenarios with anticipated heavy INVIMA query volume, confirm in the engagement letter whether substantive query responses are inside the annual fee or billable at $150/hour ad-hoc. The same qualifier applies to FSCA drafting, post-market surveillance reporting, and importer-audit support if INVIMA conducts an inspection.

Scenario A: Single Class IIa Device, 3-Year Total

A typical Class IIa on the uncontrolled pathway: immediate approval upon submission, post-approval technical file review, 1–2 modifications per year, UDI-DI submission per Resolution 2024041.

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 setup + filing	$6,000 (40 hrs × $150)	$4,000 ($1,500 setup + $2,500 filing)	$2,000
Year 1 UDI-DI + 1 modification	$1,500 (10 hrs)	$1,000 (1 mod × $700 + UDI setup)	included
Year 1 total	$7,500	$5,000	$2,000
Year 2 maintenance	$2,500 (16 hrs)	$1,800 annual + $700 mod	$2,000
Year 3 maintenance	$2,500 (16 hrs)	$1,800 annual + $700 mod	$2,000
3-Year Total	$12,500	$10,000	$6,000
Year 1 share of 3-year spend	60%	50%	33%

The Year 1 burden under flat fee is $2,000 vs $7,500 under hourly — for the same regulatory output. That $5,500 of cash that does not leave the company in Year 1 is, for an early-stage MedTech, often the difference between launching in Colombia this fiscal year and deferring 12–18 months. Under the uncontrolled pathway INVIMA grants approval immediately on a complete submission, so the cash savings convert directly into earlier revenue.

Scenario B: Single Class III Device, 3-Year Total

A typical Class III on the controlled pathway: 6–8 months of INVIMA review, full clinical dossier, multiple INVIMA queries, 1–2 Technical Modifications/year post-approval, and the Year-10 renewal.

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 setup + dossier filing	$15,000 (95 hrs × $158 blended)	$9,000 ($3,000 setup + $6,000 filing)	$3,000
Year 1 INVIMA query responses	$2,000	$1,500	included
Year 1 UDI-DI + 1 modification	$2,000	$1,500	included
Year 1 total	$19,000	$12,000	$3,000
Year 2 maintenance	$4,000 (25 hrs)	$3,500 annual + $1,200 mod	$3,000
Year 3 maintenance	$4,000 (25 hrs)	$3,500 annual + $1,200 mod	$3,000
3-Year Total	$27,000	$21,400	$9,000
Year 1 share of 3-year spend	70%	56%	33%

Under hourly, 70% of the 3-year rep cost lands in Year 1 — the worst possible time for a Colombia entrant who has not yet earned local revenue. Flat fee distributes the same scope evenly, freeing $16,000 of Year 1 working capital for clinical evidence, training materials, or sales hires.

Scenario C: 5-Device Portfolio (3 Class IIa + 2 Class IIb)

The flat-fee tier discount compounds dramatically. Pure Global's table charges $4,000/year for 3 Class IIa and $4,500/year for 2 Class IIb, totaling $8,500/year flat for the full 5-device portfolio.

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 total	$40,000–$60,000	$25,000–$40,000	$4,000 (3 Class IIa) + $4,500 (2 Class IIb) = $8,500
Year 2	$13,000–$22,000	$11,000–$18,000	$8,500
Year 3	$13,000–$22,000	$11,000–$18,000	$8,500
3-Year Total	$66,000–$104,000	$47,000–$76,000	$25,500

For multi-device portfolios, the flat-fee tier discount (each additional device is incremental, not multiplicative) compounds savings. A 5-device portfolio at Pure Global's published rates costs less than a single Class III device under hourly billing.

What "All-Inclusive" Actually Means: Scope Checklist

When proposals all claim to "include everything," the differences are in the fine print. Use this checklist to compare proposals line by line.

Service Item	Hourly (typical)	Reg + Annual (typical)	Flat Fee — Pure Global
Initial INVIMA registration filing	hourly	one-time setup fee	included (published)
Spanish translation of submission documents	hourly	sometimes included, sometimes per-page	included (published; "required translation")
Legal Modifications (labeling, manufacturer, holder)	hourly per modification	$400–$1,200 each	included (published; "modifications")
Technical Modifications (specs, intended use)	hourly per modification	$600–$2,500 each	included (published; "modifications")
Combined Legal & Technical Modifications	hourly	$1,000–$3,500 each	included (published; "modifications")
INVIMA queries / clarification responses	hourly	hourly above contract scope	confirm with provider — "correspondence with authorities" is published, but substantive Class IIb/III query response is not separately itemized
UDI-DI submission in IDIS (Resolution 2024041)	hourly per code	$50–$200 per code	included if required (published; "support with UDI-DI codes submission")
Registration renewal at Year 10	hourly	$2,500–$6,000 extra	included (published; "renewals")
CCAA Importer Certificate arrangement	not in scope	$500–$2,500/year extra	included if required (published)
Pure Colombia as registration owner	not offered	not offered	included if required (published)
Acting as INVIMA point of contact for the device	hourly	included	inherent to statutory role under Decreto 1782/2014
Forwarding INVIMA correspondence to manufacturer	hourly per email	included	inherent to statutory role under Decreto 1782/2014
Technovigilance forwarding (per Resolución 4816/2008)	hourly	hourly or per-event	confirm with provider — forwarding may be inherent; analysis/FSCA drafting is ad-hoc at $150/hr
Technovigilance investigation / FSCA drafting	hourly	hourly or per-event	separate — $150/hr (ad-hoc consulting)
Post-market surveillance reporting beyond forwarding	hourly	hourly	confirm with provider
Inspection support if INVIMA audits importer/holder	hourly	hourly	confirm with provider
CCAA importer-data updates after initial certificate	hourly	hourly	confirm with provider
Coordination with importer / customs broker	hourly	sometimes included	not included (importer's role)
Trademark filing with SIC	not in scope	$800–$2,000 + government fee	separate — $1,500 (consulting menu) + SIC fee at cost
Certified translations for non-INVIMA authorities	hourly	extra	not included; per-page translation menu ($7/page; $4/page review) for non-bundled translations
Importation handling and customs brokerage	not in scope	not in scope	not included
INVIMA government fees	passed through	passed through	passed through at cost (no markup)
SIC trademark government fee	passed through	passed through	passed through at cost (no markup)

The scope items that quietly drive Year-2-and-beyond cost overruns under hourly and reg-plus-annual models are: Technical Modifications, UDI-DI per-code submissions, and INVIMA query responses. Together they generally account for 35–60% of post-Year-1 rep spend. Modifications and UDI-DI submissions are explicitly inside Pure Global's flat fee; INVIMA query handling sits in a "correspondence with authorities" line that is included on the published list but not separately itemized for substantive Class IIb/III dossier queries — confirm scope in writing before signing.

The CCAA Importer Certificate line is a sleeper — many manufacturers do not realize until after signing that some reps expect you to source and pay for an independent CCAA-certified importer separately. Pure Global's price list includes the CCAA Importer Certificate "if required," meaning the issuance of the certificate itself is bundled; the actual physical importation and any subsequent CCAA-data updates are not, and remain a separate commercial relationship with the importer.

Recommended Reading

Brazil Medical Device Registration Cost 2026: BRH Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

ANVISA Reimbursement & Market Access2026-04-24 · 34 min read

What 2026 Colombia Regulatory Churn Costs Under Each Pricing Model

Colombia's regulatory environment between 2022 and 2026 has been more active than at any time since Decree 4725 was originally issued in 2005. Each rule change forces existing registrations to file modifications, generate UDI-DI submissions, repackage technical files, or update labeling. Under hourly or reg-plus-annual, every one of those filings is a billable event. Under flat fee, they are not. This is where the case for flat fee gets quantitatively compelling.

Modification Volume from 2022–2026 INVIMA Rules

The table below shows the cumulative modification load that a typical device on the Colombian market has had to absorb in the four years since the modernization push began.

Regulation	Effective	Modification Type Triggered	Typical Modifications per Device
Resolution 1405/2022 (UDI-DI framework)	February 2022, phased	Initial UDI-DI assignment and IDIS upload	1–2 filings
Resolution 2024041 (UDI-DI mandatory submissions)	2024	Expanded UDI-DI obligations for IDIS, semantic reporting	1–2 filings
IDIS (INVIMA Digital Information System)	2024–2025 launch	Account migration, electronic resubmission of legacy files, e-signature credentials	1 systemic re-submission per holder
Resolution 4002 of 2007 (refresh)	Ongoing	Labeling and IFU clarifications, GMP statements	1–2 per device per year
Decreto 410 of 2024 (sanitary registration modernization)	Phased 2024–2026	Renewal-cycle realignment, holder data updates, registration data refresh	1 filing per device
EU MDR/IVDR alignment for high-risk devices	Phased 2025–2027	Essential principles statements, technical file restructuring for IIb/III	1–2 filings (Class IIb/III)
CCAA importer-data updates	Ongoing	Importer changes, distribution-network updates	1 per importer change

A typical Class IIa device has filed 4–8 cumulative modifications since 2022. Class IIb and III devices, with broader EU MDR/IVDR alignment scope, are closer to 6–12 filings.

What That Modification Volume Costs You

Pricing Model	Per-Filing Cost	4-Year Cost (Class IIa, 5 filings)	4-Year Cost (Class III, 10 filings)
Hourly billing (3–7 hrs × $215 blended)	$645–$1,505	$3,225–$7,525	$6,450–$15,050
Reg fee + annual ($400–$2,500 each)	$400–$2,500	$2,000–$12,500	$4,000–$25,000
Pure Global flat fee	included	$0 incremental	$0 incremental

Under hourly or reg-plus-annual, regulatory churn becomes a hidden tax that scales with how active the regulator is — not with how active you are. INVIMA, as a Level 4 PAHO/WHO authority and IMDRF member, is one of the more active medical device regulators in Latin America. That is exactly the wrong environment for a 3-year hourly contract.

What INVIMA Has Queued for 2026–2028

The pipeline already in consultation or scheduled, each of which will trigger fresh filings:

• Decreto 410 of 2024 implementing resolutions — additional implementing resolutions through 2027, including expedited-review pathways for reliance markets (FDA, EU, Health Canada, PMDA, TGA).
• Successor decree to Decree 4725/2005 — Regulatory Impact Analysis (Análisis de Impacto Normativo) in progress; the successor decree is expected to incorporate further EU MDR/IVDR elements, formal ISO 13485 GMP recognition, and IMDRF common data elements.
• UDI-DI phased rollout under Resolutions 1405/2022 and 2024041 — Class IIa pre-Feb-2024 devices had a Feb 9, 2026 deadline; higher-risk classes follow on phased deadlines through 2028.
• IDIS expansion — new modules for technovigilance, post-market surveillance, and renewal management through 2027, each requiring re-credentialing.
• Trademark renewal cycle — SIC trademark protection is 10 years renewable; renewal coordination is increasingly bundled into rep scope.

A reasonable 2026–2028 forecast for an existing Class III device is 3–5 additional modifications. At hourly rates that is another $1,500–$8,500 per device. Under flat fee, $0.

For a portfolio holder with 5 Class III devices, the difference between "modifications included" and "modifications billable" over 2026–2028 is roughly $7,500–$42,500 in net Colombia P&L impact — same regulatory work, same outcome with INVIMA, just different invoice line.

When Flat Fee Wins, and When It Does Not

Flat fee is not universally the best choice. The decision framework:

Flat fee usually wins when:

• You expect to keep the device on the Colombian market for ≥3 years (the standard contract length).
• You have ≥2 devices in your Colombia portfolio (tier discounts compound).
• Your devices are commercially active — ongoing labeling updates, importer changes, UDI-DI submissions, and Technical Modifications.
• You are pre-revenue or capital-constrained in Year 1 and want to smooth cash outflow ahead of the controlled-pathway 6–8 month review.
• Your portfolio includes Class IIb/III devices that will absorb EU MDR/IVDR alignment churn in 2025–2027.
• You want the registration owned by an independent representative rather than a distributor.

Hourly billing might still win when:

• You are doing a one-time discovery exercise (e.g., regulatory feasibility for the Andean market) with no registration to maintain.
• You have a single Class I device that you expect to file once on the uncontrolled pathway and never modify.
• You need ad-hoc strategic counsel (technovigilance investigation, trademark dispute) outside an existing rep relationship.

Registration-fee-plus-annual is rarely the optimal choice on TCO grounds. It typically lands between hourly and flat fee on cost while preserving Year 1 front-loading. It also leaves the Year-10 renewal cliff and trademark renewals as un-budgeted line items.

Government Fees: A Quick Reference

Colombia Representative service fees are excluded from INVIMA government fees in every model. For completeness, the official 2026 government fees are below. Conversions use COL 4,200 = USD 1.

Filing	Government Fee (COL)	Approximate USD
Medical Device Class I — Application Assessment	COL 3,898,330	~$928
Medical Device Class IIa — Application Assessment	COL 3,898,330	~$928
Medical Device Class IIb — Application Assessment	COL 4,412,400	~$1,051
Medical Device Class III — Application Assessment	COL 4,412,400	~$1,051
IVD Class I — Application Assessment	COL 2,570,590	~$612
IVD Class II — Application Assessment	COL 2,570,590	~$612
IVD Class III — Application Assessment	COL 3,427,327	~$816
Trademark Application (per mark, SIC)	COL 1,288,000 – 1,714,500	~$307–$408
Legal Modification (administrative)	COL 866,471	~$206
Technical Modification	COL 1,111,456	~$265
Legal & Technical Modification (combined)	COL 1,259,319	~$300
UDI-DI Code Addition (up to 182 codes)	COL 13,200	~$3

For a complete breakdown including legal-representative fees and document translation, see the companion guide: Colombia INVIMA Medical Device Registration: Complete Guide.

Recommended Reading

Costa Rica Medical Device Registration Guide: Ministry of Health Process, Spanish Documentation, and LATAM Strategy

Regulatory Commercialization2026-04-24 · 13 min read

8 Questions to Ask Any Colombia Rep Before You Sign

Demand explicit, written answers before signing — not verbal assurances during the sales call.

1. Is the fee fixed for the contract term, or subject to annual escalation? If escalation: capped at what (Colombia IPC? USD-pegged? uncapped?). Colombia's IPC has run 6–13% in recent years, so uncapped CPI clauses erase any nominal "discount."
2. Is the CCAA Importer Certificate included or separately quoted? Many reps quote a low base fee, then add $500–$2,500/year for CCAA once the contract is signed.
3. Does the registration list your rep or a distributor as holder? If distributor, switching distributors typically forces re-registration. Demand independent-rep ownership in writing.
4. How many modifications are included per year, split between Legal, Technical, and combined? Cap per device or per portfolio? What counts as a "modification" — labeling? IFU? manufacturer change?
5. How many UDI-DI code submissions are included per year? Per Resolution 2024041, every variant requires a code. "Reasonable use" is a red flag.
6. What is the per-hour rate for out-of-scope work? Some firms advertise low base fees and charge $300+/hour for anything out of scope. Pure Global's published ad-hoc rate is $150/hour.
7. Who pays if INVIMA issues a clarification request during controlled-pathway review? Under hourly, you do. Under flat fee, the rep should. Confirm in writing.
8. What are the termination terms? Pure Global publishes 50% payoff of remaining contract value. Many competitors require 100% payoff or 12-month notice. Ask in writing whether the rep will issue a transfer letter at no cost if you leave, and whether they reserve any right to retain the registro sanitario during a dispute.

If a rep refuses to answer any of these in writing, that is the answer.

Colombia Rep Switching Playbook: How to Leave Without Getting Trapped

The single most expensive mistake in Colombia Representative selection is signing a contract you cannot exit affordably. Many manufacturers discover, 18 months in, that their rep is mediocre but switching costs more than staying. This section is the operational playbook competitors avoid publishing.

The INVIMA Holder Change Procedure

INVIMA permits transfer of the registration holder via the online platform (tramites.invima.gov.co) under the Decree 1782/2014 framework. The mechanic:

Step	Who Performs	Typical Duration	Notes
1. Manufacturer issues new Power of Attorney to incoming representative	Manufacturer + new rep	2–4 weeks	Apostilled (Hague Convention — Colombia is a member)
2. Outgoing representative issues transfer letter / consent	Outgoing rep	0 days to 6 months	This is the choke point. Some firms drag this through the full notice period.
3. New representative files Modificación Legal — change of holder	New rep	30–90 days INVIMA processing	Combined Legal Modification fee COL 866,471
4. Outgoing representative cancels its association	Outgoing rep	30 days	Mostly mechanical
5. Updated certificate issued by INVIMA	INVIMA	30–60 days	Public via INVIMA Consultas Web
6. CCAA importer notification updated	New rep + importer	2–4 weeks	Required for customs continuity
7. IDIS / UDI-DI account credentials transferred	New rep	2–6 weeks	Tied to holder identity
Total realistic timeline		90–180 days uncontrolled, 120–240 days controlled	Faster if outgoing rep cooperates

The bottleneck is almost always step 2. INVIMA will not process a holder change without a transfer letter from the outgoing holder. A rep that wants to retain you can effectively delay your departure by stalling on this single document.

Contract Termination Clauses: How They Actually Compare

The termination clause buried in your Colombia Representative agreement is often more economically consequential than the headline annual fee. Common terms in the market:

Termination Term	Typical Industry Practice	Pure Global Published Term
Notice period required	6–12 months	None — termination effective on contract anniversary
Payoff of remaining contract value on early exit	100% of remaining contract	50% payoff of remaining contract
Transfer letter delivery commitment	Within "reasonable time" (undefined)	Standard contract term
Separate "transfer fee" charged at exit	$1,000–$4,000 typical	None
Right to withhold registro sanitario	Sometimes asserted	Explicitly waived in published terms

If you sign a typical industry contract requiring 12 months notice plus 100% payoff of remaining term, the effective cost of switching mid-contract on a $4,000/year deal is $4,000 (notice) + $8,000 (2-year payoff) + $2,500 (transfer fee) = $14,500 before you pay the new rep a cent. That is more than 4 years of flat-fee under Pure Global's published rate for a single Class IIa device.

The Distributor-as-Representative Lock-In Trap

The most common trap for first-time Colombia entrants: letting the in-country distributor or the CCAA-certified importer double as the Representante Legal. Up front this looks efficient — one relationship, no separate retainer, often "free" as part of the commercial deal. The economic reality is harsher.

If your distributor or importer holds the registro sanitario:

• Switching distributors often requires re-registration, not just a holder transfer. Some Colombian distributors structure the registration so tightly to their CCAA infrastructure that a clean transfer is operationally difficult.
• The distributor has implicit veto power over your Colombian commercial strategy. Add a second importer? They can refuse to update the CCAA listing. Renegotiate margins? They can drag transfer letters. Terminate for non-performance? You face re-registration delay risk during which you cannot import.
• The "free representative" is always priced into the distributor margin. Industry practice is 8–18% commercial markup. For a $3M/year Colombia business, that is $240,000–$540,000/year in implicit representative cost — paid to the same firm whose interests can diverge from yours.

The right structure: an independent Colombia Representative holds the registro sanitario, and one or more CCAA-certified importers are authorized importers under that registration. Switching distributors becomes a commercial decision, not a regulatory one. This is exactly why Pure Global's published terms include "Pure Colombia as the owner of the registration" as a default — it structurally prevents the distributor lock-in trap.

Clean Switching: 7-Step Sequencing

1. Sign the new rep first, with the contract conditional on successful transfer of named registros sanitarios.
2. Generate fresh Powers of Attorney in parallel. Apostille (Colombia is a Hague Convention member — no consular legalization required).
3. Time the notice letter to land 30 days before the contract anniversary to minimize early-termination cost.
4. Cite specific contract clauses in your termination letter (transfer letter delivery commitment in particular). Reps respond to legal pressure, not commercial requests.
5. File the Modificación Legal — cambio de titular the day you receive the transfer letter — do not wait.
6. Hold CCAA importer continuity — the incoming rep should ensure the CCAA-listed importer is not interrupted. Gaps mean stuck shipments.
7. Confirm IDIS / UDI-DI credentials transfer — the IDIS account is tied to the holder's NIT; a switch requires new credentials.

A well-executed switch costs $2,000–$5,000 and 90–180 days. A poorly executed switch can cost a year of market access. The termination clause is the upstream variable — negotiate it hardest before signing.

Named Provider RFP Comparison: Pure Global vs Typical Competitor Quotes

We modeled the same scope — single Class IIa medical device, 3-year rep relationship, standard inclusions — under three pricing structures: Pure Global (rates verified on its public pricing page), and two composite industry quotes (hourly billing, reg-plus-annual) built from typical Colombia RFP responses.

The comparison uses the midpoint of each composite range. Competitor firms (Emergo, Freyr, Artixio, MedEnvoy, Veraque, MDRC, bioaccess, plus Bogotá and Medellín boutiques) are not named individually because, unlike Pure Global, they do not publish prices.

Same Scope, Three Models, 3-Year Total

Scope baseline: 1 Class IIa medical device, INVIMA registro sanitario under the uncontrolled pathway (Decree 4725/2005 framework, Decreto 410/2024 modernization), foreign manufacturer, 3-year contract, average commercial activity (1 importer, 1 trademark, 1–2 modifications per year, 5–10 UDI-DI codes per year per Resolution 2024041).

Line Item	Pure Global (Flat Fee)	Composite Hourly Quote	Composite Reg+Annual Quote
Year 1 — initial filing & setup	$2,000 (annual fee)	$6,000 (40 hrs × $150 blended)	$4,500 ($1,500 setup + $3,000 filing)
Year 1 — Spanish translation	included	$1,200 (8 hrs T3)	$700–$1,500 bundled or $7–$12/page
Year 1 — UDI-DI submission (10 codes)	included, unlimited	$750 (5 hrs T3)	$500–$2,000 (per-code fees)
Year 1 — CCAA Importer Certificate arrangement	included	$750 (5 hrs T2)	$500–$2,500 separately quoted
Year 1 — 1 modification	included	$470 (2 hrs T2)	$400–$1,200
Year 1 total	$2,000	$9,170	$6,600–$11,700
Year 2 — annual maintenance	$2,000	$2,500 (16 hrs blended)	$1,800–$2,500 base
Year 2 — 2 modifications + 5 UDI-DI codes + CCAA	included	$1,820	$1,150–$5,500
Year 3 — annual maintenance	$2,000	$2,500	$1,800–$2,500
Year 3 — 2 modifications + 5 UDI-DI codes + CCAA	included	$1,820	$1,150–$5,500
3-Year Total	$6,000	$17,810	$12,500–$27,700

(Pure Global rates verified at pureglobal.com/services/pricing. Composite ranges drawn from typical Colombian Representative RFP responses observed by MedDeviceGuide; individual firm numbers vary.)

Key Takeaways from the Comparison

• Pure Global at the published rate is 3.0x cheaper than the composite hourly quote over 3 years, and 2.1x to 4.6x cheaper than the composite reg+annual quote.
• The cost gap widens in Years 2 and 3 if the device generates above-average modifications — which, given 2026 INVIMA churn (Decreto 410, IDIS, UDI-DI 2024041, EU MDR/IVDR alignment), is the realistic case for Class IIb/III devices.
• The reg-plus-annual model has the widest bracket because providers vary enormously on whether modifications, UDI-DI submissions, and the CCAA arrangement are inside the annual fee. Read every "included" claim line by line.
• The flat-fee model is insulated from invoice variance. The only variable is whether you signed Class I/IIa or IIb/III pricing.

Why Composite Instead of Named Competitors

No other major Colombia Representative provider publishes prices, so naming Firm X with a specific number invites disputes we cannot resolve without violating NDAs. The point of this analysis is the structural difference between pricing models, not which specific competitor is best. If you want firm-specific pricing, issue your own RFP — the next section gives you a template designed to force apples-to-apples comparisons.

Recommended Reading

Clinical Equivalence Assessment Under EU MDR: Technical, Biological, and Clinical Equivalence

Clinical Evidence EU MDR / IVDR2026-04-24 · 12 min read

Colombia Rep RFP Template Copy and Paste

Most Colombia Representative RFPs come back in three different formats with three different scope inclusion lists, making side-by-side comparison nearly impossible. Use the template below to force every responding firm into the same structure. Copy, paste, fill in the blanks, send.

---

Subject: Request for Proposal — Colombia Representative (Representante Legal) Services for [Manufacturer Name]

Dear [Provider],

[Manufacturer Name] is evaluating Colombia Representative service providers for our medical device portfolio entering or maintaining presence in the Colombian market via INVIMA registro sanitario. We are issuing this RFP to [N] firms and request a written proposal by [date].

Portfolio Scope

#	Device Name	INVIMA Class	Pathway (Uncontrolled / Controlled)	Currently Registered?	Trademark Required?	Anticipated Modifications/Year
1	[Device A]	[I / IIa / IIb / III]	[Uncontrolled / Controlled]	[Yes / No]	[Yes / No]	[N]
2	[Device B]

Contract Term: We anticipate a [3-year / 5-year] Colombia Representative relationship.

Required Pricing Format

Please provide pricing in the following table for each year of the contract term. Indicate explicitly whether each line item is included in the base fee or billed separately, and if separately, on what unit basis.

Service Item	Year 1 Cost	Year 2 Cost	Year 3 Cost	Inclusion (Y/N)	Per-Unit Rate if Separate
Initial INVIMA registration filing per device
Spanish translation of submission documents
Legal Modifications — please state limit
Technical Modifications — please state limit
Combined Legal & Technical Modifications
INVIMA query / clarification responses
UDI-DI submissions in IDIS — please state per-year code limit
CCAA Importer Certificate arrangement
Registration ownership (independent rep vs distributor)
Renewal filing at Year 10
Trademark filing with SIC
Technovigilance / adverse event reporting
Out-of-scope hourly rate (T1 / T2 / T3)

Required Disclosures

1. Annual fee escalation clause — fixed, IPC-linked, USD-pegged, or uncapped?
2. Notice period required for non-renewal at end of term.
3. Early termination payoff — what percentage of remaining contract value?
4. Transfer letter delivery commitment in days from termination notice.
5. Any separate "transfer fee" charged at exit — yes/no, amount.
6. Government fees — confirm passed through at cost without markup.
7. Whether you hold the registro sanitario in trust or as agent — and whether you assert any right to withhold the registration certificate during a dispute.
8. Whether the registration will be held by your firm or by the CCAA importer — with the contract clause that determines this.

Evaluation Criteria

We will evaluate proposals on (in order): (1) total 3-year cost at our forecast scope, (2) inclusion completeness — fewer separately-billed line items is better, (3) registration-ownership independence from distributors and importers, (4) termination clause flexibility, (5) responsiveness during this RFP, (6) INVIMA filing track record (please attach 2–3 references).

Please respond by [date] to [contact email].

Best regards,

[Your Name]

[Your Title], [Manufacturer Name]

---

This template forces every rep to price the same scope. The line items where firms diverge most — modifications, UDI-DI per-code submissions, CCAA arrangement, termination clauses — are exactly the items the template makes them disclose explicitly. After three to five proposals come back in this format, the right answer is usually obvious within an hour of comparing.

Frequently Asked Questions

Is a Colombia Representative the same as a CCAA-certified importer?

No. The Representante Legal holds the registro sanitario and acts as INVIMA's regulatory point of contact. The CCAA-certified importer physically imports the device and handles customs and storage. The same entity can play both roles, but combining them is generally a bad idea — if the commercial relationship sours, the importer-as-rep controls the registration and you cannot leave without re-registering.

Can I be my own Colombia Representative?

Only with a Colombian legal entity that has the appropriate INVIMA recognition. Most foreign manufacturers find the cost of standing up a Colombian regulatory subsidiary exceeds the cost of an independent representative for the first 5–10 devices.

How long does a Colombia Representative transition take if I want to switch?

90–180 days for uncontrolled-pathway registrations and 120–240 days for controlled-pathway registrations. The current rep must issue a transfer letter; INVIMA processes the change via Modificación Legal; the new rep updates the file and IDIS / UDI-DI account. Pure Global's 50% remaining-contract-value early-termination clause is among the more buyer-friendly in the industry — many representatives require 100% payoff plus 6–12 months of notice.

Does the Colombia Representative pay government fees on my behalf?

Yes — the rep submits the INVIMA fee payment on your behalf, reimbursed by the manufacturer at cost. Reputable reps do not mark up government fees. If a rep refuses to pass through INVIMA fees at cost, walk.

What happens if INVIMA issues a clarification request during the controlled-pathway review?

Response window is 30–90 days. Under hourly billing, every hour is billed. Under registration-plus-annual, query responses are sometimes inside scope and sometimes billed separately. Pure Global's published price list includes "correspondence with authorities" but does not separately itemize substantive query response work for Class IIb/III dossier challenges, so confirm in writing whether query responses sit inside the annual fee or are billable at the $150/hour ad-hoc rate. This is one of the single largest Year-1 expense overruns for borderline Class IIb/III devices and must be settled in the engagement letter, not assumed.

Can I negotiate the flat-fee price?

Pure Global publishes the price, so the published rate is the rate. Negotiable variables are scope (number of devices, contract length), not per-device fee. For 11+ device portfolios, custom pricing applies and is negotiable on volume terms.

Do I need a separate trademark registration for my device?

Effectively yes — INVIMA registration of a medical device using a brand name requires the brand to be registered with the Superintendencia de Industria y Comercio (SIC). Without trademark protection, a competitor can register the mark first. Pure Global offers Trademark Support Colombia at $1,500 per device trademark plus the SIC government fee (COL 1,288,000–1,714,500). Many competitors do not flag this requirement until after contract signing.

How does Colombia Representative cost compare to other Latin American markets?

Colombia's rep cost under Pure Global's published flat fee runs $2,000–$8,500/year for the uncontrolled-pathway tier (1–10 Class I/IIa MD or Class I/II IVD registrations) and $3,000–$14,000/year for the controlled-pathway tier (1–10 Class IIb/III MD or Class III IVD registrations). That positions Colombia roughly in line with Mexico's COFEPRIS Authorized Representative (~$2,000–$5,000/year) and below Brazil's BRH at the high end. See LATAM Medical Device Registration Comparison and Medical Device Registration Cost by Country: 2026 Global Comparison.

Does INVIMA recognize FDA clearance or CE mark for expedited review?

Colombia does not currently have a formal reliance pathway. A Certificate of Free Sale (CFS) from FDA, EU, Health Canada, PMDA, or TGA is a required document and significantly de-risks the technical-file review. Decreto 410 of 2024 has signaled future expedited-review pathways for reliance-market submissions, with implementing resolutions expected through 2027.

Bottom Line

Colombia's government fees are not where Colombia registration budgets get blown up. The line item that wrecks budgets is the rep service fee — specifically the cash flow shape of when those fees hit, and whether the CCAA Importer Certificate, UDI-DI submissions, and modifications are inside or outside the headline annual fee. Hourly billing front-loads 60–70% of 3-year cost into Year 1. Reg-fee-plus-annual front-loads 50–56%. Flat all-inclusive flattens it to ~33% per year, which is the only pricing model that aligns with how MedTech revenue actually scales in a new market.

The numbers are 2026 benchmarks. The pricing-model questions are timeless. Ask them before you sign.

Related Guides

• Colombia INVIMA Medical Device Registration: Complete Guide for Foreign Manufacturers
• LATAM Medical Device Registration Comparison
• Brazil Medical Device Registration Cost 2026: BRH Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison
• Medical Device Registration Cost by Country: 2026 Global Comparison
• Medical Device Regulatory Consulting Hourly Rates by Region